Crescent Capital [CCAP] vs Brookfield [BN] Detailed Stock Comparison
Crescent Capital
NASDAQ
Loading...
Brookfield
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Crescent Capital wins in 12 metrics, Brookfield wins in 5 metrics, with 0 ties. Crescent Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crescent Capital | Brookfield | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.75 | 232.59 | Crescent Capital |
| Price-to-Book Ratio | 0.78 | 2.46 | Crescent Capital |
| Debt-to-Equity Ratio | 122.44 | 156.81 | Crescent Capital |
| PEG Ratio | -0.50 | 11.49 | Crescent Capital |
| EV/EBITDA | N/A | 14.75 | N/A |
| Profit Margin (TTM) | 24.12% | 0.73% | Crescent Capital |
| Operating Margin (TTM) | 75.45% | 27.05% | Crescent Capital |
| EBITDA Margin (TTM) | 75.45% | 27.05% | Crescent Capital |
| Return on Equity | 5.98% | 0.95% | Crescent Capital |
| Return on Assets (TTM) | 5.27% | 2.69% | Crescent Capital |
| Free Cash Flow (TTM) | $58.91M | $-3.60B | Crescent Capital |
| Dividend Yield | 16.67% | N/A | N/A |
| 1-Year Return | -17.43% | 31.28% | Brookfield |
| Price-to-Sales Ratio (TTM) | 3.07 | 1.24 | Brookfield |
| Enterprise Value | $1.44B | $455.84B | Brookfield |
| EV/Revenue Ratio | 7.86 | 5.45 | Brookfield |
| Gross Profit Margin (TTM) | N/A | 38.73% | N/A |
| Revenue per Share (TTM) | $5 | $55 | Brookfield |
| Earnings per Share (Diluted) | $1.19 | $0.29 | Crescent Capital |
| Beta (Stock Volatility) | 0.60 | 2.19 | Crescent Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Crescent Capital vs Brookfield Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crescent Capital | 0.07% | 3.84% | 5.20% | -2.88% | -24.20% | -21.08% |
| Brookfield | -0.67% | -1.66% | -2.80% | 8.59% | 6.53% | 12.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crescent Capital | -17.43% | -13.02% | 24.16% | -7.56% | -7.56% | -7.56% |
| Brookfield | 31.28% | 62.15% | 128.94% | 279.24% | 723.37% | 1,121.02% |
Performance & Financial Health Analysis: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Market Information | ||
| Market Cap | $562.22M | $103.45B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 165,120 | 2,772,840 |
| 90 Day Avg. Volume | 228,990 | 2,169,097 |
| Last Close | $15.17 | $64.04 |
| 52 Week Range | $13.54 - $20.19 | $43.61 - $68.75 |
| % from 52W High | -24.86% | -6.86% |
| All-Time High | $21.24 (Oct 11, 2021) | $68.75 (Jul 18, 2025) |
| % from All-Time High | -28.58% | -6.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | -0.22% |
| Quarterly Earnings Growth | -0.26% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.01% |
| Operating Margin (TTM) | 0.75% | 0.27% |
| Return on Equity (TTM) | 0.06% | 0.01% |
| Debt to Equity (MRQ) | 122.44 | 156.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.55 | $27.44 |
| Cash per Share (MRQ) | $0.26 | $8.32 |
| Operating Cash Flow (TTM) | $65.36M | $8.95B |
| Levered Free Cash Flow (TTM) | $58.51M | $-2,725,499,904 |
| Dividends | ||
| Last 12-Month Dividend Yield | 16.67% | N/A |
| Last 12-Month Dividend | $2.41 | N/A |
Valuation & Enterprise Metrics Analysis: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.75 | 232.59 |
| Forward P/E | 7.51 | 11.49 |
| PEG Ratio | -0.50 | 11.49 |
| Price to Sales (TTM) | 3.07 | 1.24 |
| Price to Book (MRQ) | 0.78 | 2.46 |
| Market Capitalization | ||
| Market Capitalization | $562.22M | $103.45B |
| Enterprise Value | $1.44B | $455.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.86 | 5.45 |
| Enterprise to EBITDA | N/A | 14.75 |
| Risk & Other Metrics | ||
| Beta | 0.60 | 2.19 |
| Book Value per Share (MRQ) | $19.55 | $27.44 |
Financial Statements Comparison: Crescent Capital vs Brookfield
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Revenue/Sales | $7.13M | $17.94B |
| Cost of Goods Sold | N/A | $11.00B |
| Gross Profit | N/A | $6.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $4.48B |
| EBITDA | N/A | $8.23B |
| Pre-Tax Income | $4.41M | $598.00M |
| Income Tax | $501,000 | $383.00M |
| Net Income (Profit) | $3.90M | $215.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Cash & Equivalents | $12.03M | $12.44B |
| Total Current Assets | N/A | $65.21B |
| Total Current Liabilities | N/A | $58.80B |
| Long-Term Debt | $902.95M | $245.86B |
| Total Shareholders Equity | $727.12M | $158.93B |
| Retained Earnings | $-232.01M | N/A |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Operating Cash Flow | $2.00M | $3.48B |
| Capital Expenditures | N/A | $-1.83B |
| Free Cash Flow | $-15.13M | $4.00M |
| Debt Repayment | $-233.04M | $-20.53B |
| Common Stock Repurchase | N/A | $-136.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CCAP | BN |
|---|---|---|
| Shares Short | 121,167 | 15.19M |
| Short Ratio | 0.44 | 8.18 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 165,120 | 2,772,840 |
| Average Daily Volume (90 Day) | 228,990 | 2,169,097 |
| Shares Outstanding | 37.06M | 1.51B |
| Float Shares | N/A | 1.17B |
| % Held by Insiders | 0.13% | 0.18% |
| % Held by Institutions | 0.65% | 0.58% |
Dividend Analysis & Yield Comparison: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Last 12-Month Dividend | $2.41 | N/A |
| Last 12-Month Dividend Yield | 16.67% | N/A |
| 3-Year Avg Annual Dividend | $2.04 | N/A |
| 3-Year Avg Dividend Yield | 1.65% | N/A |
| 3-Year Total Dividends | $6.12 | N/A |
| Ex-Dividend Date | Aug 29, 2025 | N/A |